Novogene Technology Receives $75,000,000 Series B Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=94c4096a-1d7b-4a5f-aec2-e7468ed5a827 - Date
12/1/2016 - Company Name
Novogene Technology - Mailing Address
823 Anchorage Place Chula Vista, CA 91914 USA - Company Description
Novogene is a leading provider of genomic services and solutions with cutting edge NGS and bioinformatics expertise and one of the largest sequencing capacities in the world. - Website
http://www.novogene.com - Transaction Type
Venture Equity - Transaction Amount
$75,000,000 - Transaction Round
Series B - Proceeds Purposes
The Series B financing will support strategic growth in Novogene’s global NGS service market and in clinical sequencing R&D and services. Additionally, funds from the financing will be used to enhance operating efficiency to further strengthen the company’s leadership position in the NGS industry. - M&A Terms
- Venture Investor
CMB Capital - Venture Investor
Innovation and Investment Company - Venture Investor
Sigma Group
